Latest Administration News

EDU Holdings Limited plans to voluntarily delist from the ASX, citing low share liquidity and regulatory uncertainty in the international student market. The company proposes a substantial buy-back offer to provide shareholders with an exit opportunity ahead of delisting.

NEXION Group has entered a non-binding agreement to sell its Perth data centre subsidiary to Canadian firm Carrier Connect Data Solutions for AUD 2.5 million, aiming to strengthen its balance sheet.

Dropsuite Limited’s shares are suspended from ASX trading following Federal Court approval of its acquisition by NinjaOne Australia, marking a pivotal step in the company’s transition.

Mayne Pharma has voluntarily withdrawn a speaker presentation for its contraceptive NEXTSTELLIS® following an FDA Untitled Letter concerning promotional claims. The company confirms this does not impact sales or its planned merger with Cosette.

Mayne Pharma has addressed a sharp share price decline following the public release of an FDA Untitled Letter, confirming no undisclosed material information and reaffirming compliance with ASX rules.

Queste Communications reported a strong cash inflow from investing activities in April 2025, driven by a $3 million receipt linked to the termination of an iron-ore royalty. The company ended the month with a robust cash position of over $4.1 million.

Genetic Technologies Limited has officially exited external administration following the effectuation of a Deed of Company Arrangement, marking a significant shift in its corporate governance and creditor relations.

The Takeovers Panel has received a contentious application from Keybridge Capital challenging Yowie Group’s recent private share placement, alleging breaches of takeover laws amid internal disputes within Keybridge.

EBR Systems has won FDA approval for its pioneering leadless WiSE CRT System, setting the stage for a phased US commercial rollout. The company also secured key Medicare reimbursement pathways and expanded manufacturing capacity, though financial sustainability remains a concern.

Anteris Technologies has submitted its FDA Investigational Device Exemption for the pivotal PARADIGM Trial of its DurAVR heart valve and marked a milestone of 100 patients treated, while expanding manufacturing capacity amid rising R&D costs.

5E Advanced Materials has raised $6.35 million through a private placement to advance its boron and lithium project in Southern California, aiming to strengthen U.S. supply chains and move closer to commercialization.

News Corporation has updated its financial statements to reflect the sale of Foxtel, reporting a 3% revenue increase in fiscal 2024 driven by its Digital Real Estate Services and Book Publishing segments, alongside a 66% rise in net income from continuing operations.